- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on M Protein in Norway
Total 129 results
-
Sykehuset Innlandet HFActive, not recruitingInflammation | Psychological Distress | Protein DeficiencyNorway
-
Norwegian University of Science and TechnologyThe Research Council of Norway; Nordic Myeloma Study Group, GermanyCompleted
-
Oslo University HospitalNorwegian School of Sport SciencesCompletedHemophilia A Without InhibitorNorway
-
Ullevaal University HospitalCompleted
-
Oslo University HospitalRecruiting
-
Ullevaal University HospitalCompleted
-
Norwegian University of Science and TechnologyOslo University Hospital; St. Olavs HospitalCompleted
-
Oslo University HospitalTargovax ASARecruitingMultiple Myeloma | Smoldering Multiple MyelomaNorway
-
Prometic Biotherapeutics, Inc.CompletedHypoplasminogenemia | Congenital Plasminogen DeficiencyUnited States, Norway
-
CSL BehringCompletedCongenital Coagulation Factor VII DeficiencyNetherlands, Norway
-
Oslo University HospitalCompletedHereditary Factor VIII Deficiency Disease With InhibitorNorway
-
Oslo University HospitalHelse Stavanger HF; St. Olavs Hospital; Nordic Myeloma Study GroupActive, not recruiting
-
Oslo University HospitalNordic Myeloma Study GroupActive, not recruitingMyelomaNorway, Denmark, Sweden
-
Henrik GregersenNordic Myeloma Study GroupUnknownMultiple MyelomaFinland, Denmark, Sweden, Norway, Lithuania
-
Oslo University HospitalUniversity Hospital of North Norway; Helse Stavanger HF; Haukeland University... and other collaboratorsRecruiting
-
Ida Bruun KristensenOdense Patient Data Explorative Network; Karyopharm Therapeutics IncActive, not recruitingMultiple MyelomaDenmark, Norway, Estonia
-
Nordic Myeloma Study GroupJanssen-Cilag Ltd.Unknown
-
European Myeloma NetworkSanofi; Amgen; EMN Research ItalyActive, not recruitingMultiple MyelomaCzechia, Germany, Greece, Italy, Netherlands, Norway, Spain
-
Stichting Hemato-Oncologie voor Volwassenen NederlandActive, not recruitingSmouldering MyelomaNetherlands, Norway, Czechia, Italy
-
Nordic Myeloma Study GroupNordic Cancer UnionCompletedMultiple MyelomaDenmark, Norway, Sweden
-
Genentech, Inc.RecruitingMultiple MyelomaSpain, Australia, Denmark, Norway
-
BayerCompletedHemophilia ABulgaria, Spain, Italy, Poland, Greece, Norway, Denmark
-
OnxeoCompletedMultiple MyelomaUnited States, Denmark, United Kingdom, Norway
-
Laboratoire français de Fractionnement et de BiotechnologiesCompletedVon Willebrand DiseaseNorway, Germany, Italy, Belgium, Czechia, Finland, Greece
-
Genentech, Inc.RecruitingMultiple MyelomaAustralia, Spain, Israel, Korea, Republic of, Greece, Norway, Denmark
-
Genentech, Inc.CompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaBelgium, Australia, Denmark, Norway
-
European Myeloma NetworkJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaNorway, Denmark, Netherlands, Czechia, Australia, Turkey, Spain, Belgium, Switzerland, France, Greece, Italy, Poland
-
Multiple Myeloma Research FoundationTerminated
-
Swedish Orphan BiovitrumCerner EnvizaCompletedHemophilia A With InhibitorFrance, Ireland, Italy, Norway, Germany, Kuwait, Saudi Arabia, Switzerland
-
Nordic Myeloma Study GroupJanssen-Cilag Ltd.CompletedMultiple MyelomaNorway, Sweden, Denmark, Finland, Iceland
-
Nordic Myeloma Study GroupCompletedMultiple MyelomaDenmark, Sweden, Norway
-
Raija SilvennoinenTakeda; Celgene; Nordic Myeloma Study GroupActive, not recruitingMultiple MyelomaNorway, Sweden, Finland, Lithuania
-
Swedish Orphan BiovitrumCerner EnvizaActive, not recruitingHemophilia BCzechia, Greece, Ireland, Italy, Norway, Saudi Arabia, Spain, Sweden, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingMultiple Myeloma (MM)United States, Italy, Israel, Germany, Japan, Spain, Australia, Norway
-
Mundipharma-EDO GmbHTerminatedMultiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma ProgressionSwitzerland, United States, Norway
-
Bristol-Myers SquibbRecruitingMultiple MyelomaNorway, United States, Spain, United Kingdom, Canada
-
European Society for Blood and Marrow TransplantationCompletedMultiple MyelomaAustria, Denmark, Germany, Finland, Canada, Sweden, Norway, France, Italy, United Kingdom, Turkey
-
Hoffmann-La RocheCompletedMultiple MyelomaSpain, Denmark, Netherlands, Sweden, Poland, France, Germany, Czechia, Norway
-
Swedish Orphan BiovitrumICON plcCompletedHemophilia AFrance, Italy, Norway, Sweden, United Kingdom, Austria, Belgium, Finland, Spain
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireTerminatedHemophilia ANetherlands, Spain, Italy, Turkey, Bulgaria, United States, Canada, Germany, Norway, Poland, Russian Federation, South Africa
-
Stichting European Myeloma NetworkPfizerRecruitingSmoldering Multiple MyelomaNetherlands, France, Italy, Finland, Greece, Norway
-
Stichting European Myeloma NetworkJanssen PharmaceuticaRecruitingMultiple MyelomaUnited Kingdom, Czechia, Australia, Austria, Belgium, Denmark, Germany, Greece, Italy, Netherlands, Norway, Serbia, Switzerland, Turkey, Brazil
-
BayerActive, not recruitingHemophilia ACanada, Japan, Spain, United States, Germany, Sweden, Belgium, Brazil, Greece, Italy, Netherlands, Taiwan, Denmark, Kuwait, Saudi Arabia, United Arab Emirates, Norway, Colombia, Switzerland, Slovenia
-
Oncopeptides ABTerminatedRelapsed Multiple Myeloma | Relapsed-Refractory Multiple MyelomaSerbia, Greece, Russian Federation, Czechia, Bulgaria, Georgia, Norway, Poland, Spain, Ukraine, Germany
-
OctapharmaCompletedHemophilia ANorway, United States, France, United Kingdom, Italy, Czechia, Argentina, Belarus, Ecuador, Guatemala, Lithuania, Portugal, Slovakia
-
Novo Nordisk A/SEnrolling by invitationHaemophilia BCanada, United Kingdom, Czechia, Germany, Greece, Austria, Belgium, Croatia, Denmark, Finland, Norway, Portugal
-
Swedish Orphan BiovitrumSyneos HealthActive, not recruitingHemophilia A, SevereGermany, Spain, France, Czechia, Netherlands, Ireland, Austria, Croatia, Greece, Italy, Norway, Slovenia, Sweden, United Kingdom
-
AstraZenecaTerminatedElevated High-sensitivity C-Reactive Protein (hsCRP)United States, Brazil, Bulgaria, Poland, Russian Federation, South Africa, United Kingdom, Germany, Estonia, Romania, Denmark, Netherlands, Norway, Canada, Mexico, Belgium, Israel, Puerto Rico, Colombia, Argentina, Venezuela, Panama, Urugu... and more
-
European Organisation for Research and Treatment...Active, not recruitingMalignant Neoplasm of Stomach | Malignant Neoplasm of Cardio-esophageal Junction of Stomach | Epidermal Growth Factor Receptor (EGFR) Protein OverexpressionSpain, Korea, Republic of, Singapore, Switzerland, Germany, United Kingdom, Italy, France, Estonia, Belgium, Netherlands, Norway, Portugal
-
Novartis PharmaceuticalsNo longer availableMultiple MyelomaGermany, Austria, Canada, Jordan, Norway, Sweden